Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. (Q39664105)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 August 2010

Language	Label	Description	Also known as
English	Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.	scientific article published on 24 August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Timothy L Frankel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ken-Ichi Hanada

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Steven Rosenberg

8

object named as

Steven A Rosenberg

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

7

object named as

Martha Quezado

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

William Burns

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

John Riley

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Richard A Morgan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jeremy L Davis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Richard E Royal

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 August 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

59

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1757-1769

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

https://scigraph.springernature.com/pub.10.1007/s00262-010-0897-y

0 references

Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0897-Y

21 January 2018

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology of human natural killer-cell subsets

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human natural killer cell development and biology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NKG2D ligands in tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20734041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00262-010-0897-Y

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39664105&oldid=1903419048"